Skip to main content
All lobbying clients

Pharmavite LLC

Pharmavite LLC has lobbied on its own behalf and been represented by 1 lobbying firm in 14 filings since 2025, with $910,000 in reported spending; the newest was posted November 7, 2026.

As filed: PHARMAVITE LLC. Client based in California.

$910,000 Reported spend
14 Filings counted
1 Outside firm hired
23 Bills named

Spend is reported income plus in-house expenses across 14 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 2 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well.

 Who filed for this client 2

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 23
  • S. 2341
    A bill to amend the Food, Agriculture, Conservation, and Trade Act of 1990 to authorize grants for eligible i…
    6 filings
  • H.R. 4121
    Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
    6 filings
  • H.R. 4306
    Food Chemical Reassessment Act of 2025
    6 filings
  • S. 2256
    Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
    6 filings
  • H.R. 4968
    Protecting and Preserving Social Security Act
    5 filings
  • S. 1071
    National Defense Authorization Act for Fiscal Year 2026
    4 filings
  • H.R. 3838
    Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fisc…
    3 filings
  • H.R. 4958
    GRAS Act
    3 filings
  • H.R. 7291
    GRAS Oversight and Transparency Act
    3 filings
  • H.R. 7366
    Dietary Supplement Regulatory Uniformity Act
    3 filings
  • H.R. 8370
    Dietary Supplement Listing Act of 2026
    3 filings
  • H.R. 8385
    Food Labeling Modernization Act of 2026
    3 filings
  • S. 2296
    National Defense Authorization Act for Fiscal Year 2026
    3 filings
  • S. 3677
    Dietary Supplement Listing Act of 2026
    3 filings
  • S. 3797
    Prohibiting Tianeptine and Other Dangerous Products Act of 2026
    3 filings
  • H.R. 8933
    Dietary Supplements Access Act
    2 filings
  • H.R. 8962
    PERFECT Act of 2026
    2 filings
  • S. 4587
    Dietary Supplements Access Act
    2 filings
  • S. 4626
    PERFECT Act of 2026
    2 filings
  • H.R. 10336
    Dietary Supplement Innovation Act
    1 filing
  • H.R. 8413
    SECURE Data Act
    1 filing
  • S. 1100
    Nutritious SNAP Act of 2025
    1 filing
  • S. 1129
    Dietary Guidelines Reform Act of 2025
    1 filing
 Reported by year 2 years
  • 2026 $390,000 6 filings
  • 2025 $520,000 8 filings
 Issues lobbied 7

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 6
  • HOUSE OF REPRESENTATIVES 14
  • SENATE 14
  • Commerce, Dept of (DOC) 9
  • Defense, Dept of (DOD) 6
  • Food & Drug Administration (FDA) 4
  • U.S. Trade Representative (USTR) 3
 Recent filings 14 total
Q3 report
Pharmavite LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $90,000 expenses · posted Nov 7, 2026
View → Q3 report
Reinecke Strategic Solutions, Inc.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 8, 2026
View → Q2 report
Pharmavite LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $90,000 expenses · posted Aug 7, 2026
View → Q2 report
Reinecke Strategic Solutions, Inc.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 20, 2026
View → Q1 report
Pharmavite LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $90,000 expenses · posted May 6, 2026
View → Q1 report
Reinecke Strategic Solutions, Inc.
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted Apr 10, 2026
View → Q4 report
Pharmavite LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $90,000 expenses · posted Feb 6, 2026
View → Q4 report
Reinecke Strategic Solutions, Inc.
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $40,000 income · posted Jan 12, 2026
View → Q3 report
Pharmavite LLC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $90,000 expenses · posted Nov 6, 2025
View → Q3 report
Reinecke Strategic Solutions, Inc.
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 13, 2025
View → Q1 report
Pharmavite LLC
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $90,000 expenses · posted Jul 21, 2025
View → Q2 report
Pharmavite LLC
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $90,000 expenses · posted Jul 21, 2025
View → Q2 report
Reinecke Strategic Solutions, Inc.
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 3, 2025
View → Q1 report
Reinecke Strategic Solutions, Inc.
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted Apr 18, 2025
View →

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem